BRCA1 and ovarian carcinoma: Mutations in these domains were strongly associated with hereditary breast and ovarian cancers [-]. Currently, 108 missense mutations in the BRCT domain of BRCA1 were reported in the BIC database (https://research.nhgri.nih.gov/bic/), but the clinical significance of only 7% of them is known.